COMPASS Pathways plc (NASDAQ:CMPS) is listed among the Best Get Rich Fast Stocks to Buy Right Now, with a majority of analysts giving it a ‘Buy’ rating and a target price range of $8 to $40. Gavin Clark-Gartner of Evercore ISI reaffirmed a ‘Hold’ rating with a price target of $8 on December 17.

Oppenheimer upgraded COMPASS Pathways plc (NASDAQ:CMPS) to Outperform on December 9, citing the potential of its psilocybin therapy for treatment-resistant depression. The firm sees a sales opportunity of nearly $1.5 billion for the treatment, considering the company’s current market capitalization of over $600 million.

COMPASS Pathways plc (NASDAQ:CMPS) is a London-based biotech company focused on mental health, with a commitment to mental well-being. While CMPS is seen as a promising investment, some AI stocks may offer greater upside potential with less downside risk according to analysts.

Geo Group (GEO) experienced an 11.46% drop in their earnings outlook. The company has been facing challenges in their financial performance, leading to a significant decline in their stock value.

Read more at Yahoo Finance: Why COMPASS Pathways plc (CMPS) Draws Both Optimism and Caution